SCHEMBL29497583

SCHEMBL29497583

O=C(O)N1CC2NCNC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13733916 0.79 — —
SCHEMBL3570524 0.75 CHRNB2 (0.38) —
SCHEMBL3291228 0.75 CHRNB2 (0.38) —
SCHEMBL2835362 0.75 CHRNB2 (0.38) —
SCHEMBL3832372 0.73 — —
Hydrochloric Acid SCHEMBL25345451 0.73 CHRNB2 (0.36) —
SCHEMBL3061000 0.72 MBTD1 (0.39) —
SCHEMBL653248 0.72 MBTD1 (0.39) —
SCHEMBL653249 0.72 MBTD1 (0.39) —
SCHEMBL18190538 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12180215-B2 Substituted pyrrolo[3,4-d]imidazoles as JAK inhibitors HENAN MEDINNO PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2024-12-31 — — US disclosed
EP-3932919-B1 JAK INHIBITOR COMPOUND AND USE THEREOF HENAN MEDINNO PHARMACEUTICAL TECH CO LTD (CN) 2024-06-26 — — EP disclosed
US-20230201165-A1 JAK INHIBITOR COMPOUND FOR TREATING SEVERE PNEUMONIA HENAN MEDINNO PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-06-29 — — US disclosed
US-20230192711-A1 JAK INHIBITOR COMPOUND AND USE THEREOF HENAN MEDINNO PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-06-22 — — US disclosed
US-11629148-B2 Substituted pyrrolo[3,4-d]imidazoles as JAK inhibitors HENAN MEDINNO PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-04-18 — — US disclosed
US-20220073524-A1 JAK INHIBITOR COMPOUND AND USE THEREOF HENAN MEDINNO PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2022-03-10 — — US disclosed
Send feedback